Serum vaspin levels in normal pregnancy in comparison with non-pregnant women

European Journal of Endocrinology

Volumn 164, Issue 4, 2011, Pages 579-583

  Giomisi, Athina ^a   Kourtis, Anargyros ^b   Toulis, Konstantinos A ^a   Anastasilakis, Athanasios D ^a   Makedou, Kali G ^b   Mouzaki, Maria ^a   Gerou, Spyridon ^c   Gavana, Elpida ^c   Agorastos, Theodoros ^a   Giannoulis, Charalambos ^b  

^a 424 General Army Hospital   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c 'Analysis' Laboratories   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASPIN; ADIPONECTIN; CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; COMPARATIVE STUDY; GESTATIONAL AGE; LIPID BLOOD LEVEL; PREGNANT WOMAN; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RATING SCALE;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; PREGNANCY; SERPINS;

EID: 79953183664     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-1020     Document Type: Article

References (26)

1. Briana DD & Malamitsi-Puchner A. Reviews: adipocytokines in normal and complicated pregnancies. Reproductive Sciences 2009 16 921-937. (doi:10.1177/1933719109336614)
2. Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. American Journal of Clinical Nutrition 2000 71 1256S-1261S.
3. Hida K,Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, Shikata K, Hourai S, Futami J, Watanabe E, Matsuki Y, Hiramatsu R, Akagi S, Makino H & Kanwar YS. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. PNAS 2005 102 10610-10615. (doi:10.1073/pnas.0504703102)
4. Aust G, Richter O, Rohm S, Kerner C, Hauss J, Klöting N, Ruschke K, Kovacs P, Youn BS & Blüher M. Vaspin serum concentrations in patients with carotid stenosis. Atherosclerosis 2009 204 262-266. (doi:10.1016/j. atherosclerosis.2008.08.028)
5. Klöting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Stumvoll M & Blüher M. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochemical and Biophysical Research Communications 2006 339 430-436. (doi:10.1016/j.bbrc.2005. 11.039)
6. Zvonic S, Lefevre M, Kilroy G, Floyd ZE, DeLany JP, Kheterpal I, Gravois A, Dow R, White A, Wu X & Gimble JM. Secretome of primary cultures of human adipose-derived stem cells. Molecular and Cellular Proteomics 2007 6 18-28. (doi:10.1074/mcp.M600217-MCP200)
7. Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opinion on Investigational Drugs 2008 17 327-333. (doi:10.1517/13543784.17.3. 327)
8. Gulcelik NE, Karakaya J, Gedik A, Usman A & Gurlek A. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. European Journal of Endocrinology 2009 160 65-70. (doi:10.1530/EJE-08-0723)
9. Youn B, Kloting N, Kratzsch J, Lee N, Park JW, Song E, Ruschke K, Oberbach A, Fasshauer M, Stumvoll M & Bluher M. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008 57 372-377. (doi:10.2337/db07-1045)
10. Suleymanoglu S, Tascilar E, Pirgon O, Tapan S, Meral C & Abaci A. Vaspin and its correlation with insulin sensitivity indices in obese children. Diabetes Research and Clinical Practice 2009 84 325-328. (doi:10.1016/j.diabres. 2009.03.008)
11. Lee MK, Jekal Y, Im JA, Kim E, Lee SH, Park JH, Chu SH, Chung KM, Lee HC, Oh EG, Kim SH & Jeon JY. Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification. Clinica Chimica Acta 2010 411 381-385. (doi:10.1016/j.cca.2009.12.003)
12. Handisurya A, Riedl M, Vila G, Maier C, Clodi M, Prikoszovich T, Ludvik B, Prager G, Luger A & Kautzky-Willer A. Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obesity Surgery 2010 20 198-203. (doi:10.1007/s11695-009-9882-y)
13. Ye Y, Hou XH, Pan XP, Lu JX & Jia WP. Serum vaspin level in relation to postprandial plasma glucose concentration in subjects with diabetes. Chinese Medical Journal 2009 122 2530-2533. (doi:10.3760/cma.j.issn.0366-6999.2009.21. 002)
14. El-Mesallamy HO, Kassem DH, El-Demerdash E & Amin AI. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism 2011 60 63-70. (doi:10.1016/j.metabol.2010.04.008)
15. Seeger J, Ziegelmeier M, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M & Fasshauer M. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. Journal of Clinical Endocrinology and Metabolism 2008 93 247-251. (doi:10.1210/jc.2007-1853)
16. von Loeffelholz C, Möhlig M, Arafat AM, Isken F, Spranger J, Mai K, Randeva HS, Pfeiffer AF & Weickert MO. Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. European Journal of Endocrinology 2010 162 507-513. (doi:10.1530/EJE-09-0737)
17. Caminos JE, Bravo SB, Garcés MF, González CR, Cepeda LA, González AC, Nogueiras R, Gallego R, García-Caballero T, Cordido F, López M & Diéguez C. Vaspin and amylin are expressed in human and rat placenta and regulated by nutritional status. Histology and Histopathology 2009 24 979-990.
18. Gonzalez CR, Caminos JE, Vazquez MJ, Garces MF, Cepeda LA, Angel A, Gonzalez AC, Garcia-Rendueles ME, Sangiao-Alvarellos S, Lopez M, Bravo SB, Nogueiras R & Dieguez C. Regulation of visceral adipose tissue-derived serine protease inhibitor by nutritional status, metformin, gender and pituitary factors in rat white adipose tissue. Journal of Physiology 2009 587 3741-3750. (doi:10.1113/jphysiol.2009.172510)
19. Stepan H, Kralisch S, Klostermann K, Schrey S, Reisenbüchler C, Verlohren M, Verlohren HJ, Drynda K, Blüher M, Stumvoll M, Kratzsch J, Kovacs P & Fasshauer M. Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia. Metabolism 2010 59 1054-1056. (doi:10.1016/j.metabol.2009.11.001)
20. Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, Kennedy CR, Lehnert H & Randeva HS. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 2008 57 1501-1507. (doi:10.2337/db08-0127)
21. Piechota W & Staszewski A. Reference ranges of lipids and apolipoproteins in pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology 1992 45 27-35. (doi:10. 1016/0028-2243(92)90190-A)
22. Zavalza-Gomez AB, Anaya-Prado R, Rincon-Sanchez AR & Mora-Martínez JM. Adipokines and insulin resistance during pregnancy. Diabetes Research and Clinical Practice 2008 80 8-15. (doi:10.1016/j.diabres. 2007.12.012)
23. Cortelazzi D, Corbetta S, Ronzoni S, Pelle F, Marconi A, Cozzi V, Cetin I, Cortelazzi R, Beck-Peccoz P & Spada A. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clinical Endocrinology 2007 66 447-453. (doi:10.1111/j.1365-2265.2007.02761.x)
24. Hivert MF, Sullivan LM, Fox CS, Nathan DM, D'Agostino RBS, Wilson PW & Meigs JB. Associations of adiponectin, resistin, and tumor necrosis factor-α with insulin resistance. Journal of Clinical Endocrinology and Metabolism 2008 93 3165-3172. (doi:10.1210/jc.2008-0425)
25. McLachlan KA, O'Neal D, Jenkins A & Alford FP. Do adiponectin, TNFα, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy Diabetes/Metabolism Research and Reviews 2006 22 131-138. (doi:10.1002/dmrr.591)
26. Tsai PJ, Yu CH, Hsu SP, Lee YH, Huang IT, Ho SC & Chu CH. Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus. Nutrition 2005 21 1095-1099. (doi:10.1016/j.nut.2005.03.008)